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ABSTRACT
(þ)-Grandifloracin was synthesized from sodium benzoate by means of a dearomatizing dihydroxylation that proceeds with unusual
regioselectivity. Iron diene complexes formed from the arene oxidation product permit the use of otherwise inaccessible transformations. The
synthetic material was shown to be antipodal to the natural product, thus determining the absolute configuration of grandifloracin for the first time.
()-Grandifloracin was first isolated in 1997 fromUvar-
ia grandiflora1 and has subsequently been isolated from
Uvaria rufa2a and Uvaria calamistrata.2b A concise total
synthesis of (()-grandifloracin has been reported by Qui-
deau and co-workers,3 but no enantioselective syntheses
have been reported to date. The absolute configuration of
grandifloracin has not previously been established unam-
biguously. The structure 1 shown in Figure 1 depicts
the absolute configuration expected upon comparison
of the grandifloracin structure with the coisolated natu-
ral product uvarirufone A (2), for which the absolute
configuration is reported.2a However, there has been dis-
agreement in the literature on the absolute structure of a
second coisolate, tonkineninA.2a This was initially assigned
the structure 3,4a but subsequent total synthesis led to
revised structure 4 being proposed4bf (structure 3 is never-
theless still being propagated in the literature2a). Structure 4
is zeylenone, a third coisolate of grandifloracin,1 implying
that zeylenone and tonkinenin A are in fact the same
compound. Furthermore, naturally occurring zeylenone
derivatives such as 3-O-debenzoylzeylenone 5 reportedly
Figure 1. Grandifloracin 1 (one possible enantiomeric structure
shown) and related natural products.
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have the opposite absolute configuration to zeylenone 4, as
shown by chemical correlation.5 This implies that both
configurations at the quaternary center are biosyntheti-
cally accessible, a proposal supported by previous work on
the biosynthesis of R- and β-senepoxide and related cyclo-
hexene oxides.6 In view of the above ambiguity, confirma-
tion of the absolute configuration of grandifloracin by
total synthesis is required.
Grandifloracin is believed to arise by the cyclodimeriza-
tion of 2 equivalents of precursor 6 (Scheme 1). Cyclodi-
merizations of cyclohexa-2,4-dienones areknown to exhibit
remarkable levels of regio-, site-, and stereoselectivity,
and the origins of this selectivity have been studied.7 They
have also been proposed to occur in the biosynthesis of
related natural products; of these, total syntheses of
aquaticol,8,9 asatone,10 biscarvacrol,3,9,11 bisorbicillinol,12
heterotropatrione,13 and isoheterotropatrione13 have been
reported that exploit such dimerizations. Advanced inter-
mediates toward bacchopetiolone14 and celastroidins15
accessed by such dimerizations have also been described.
Of these reported total syntheses, most accessed the
dimerization precursor by oxidative dearomatization of a
phenol, either by chemical3,8,9,10c,11,12ad,14,15 or electro-
chemical10a,b,13 methods. In Deng’s synthesis of bisorbi-
cillinol12e an alternative approachwas adopted, employing
a Claisen condensation to access the dimerization
precursor. In the context of grandifloracin, we have
adopted a conceptually distinct approach, namely micro-
bial arene dihydroxylation; this has not been employed
to date to access cyclohexa-2,4-dienone dimer natural
products.
Enzymatic dihydroxylation of arenes to produce enan-
tiopure building blocks is established methodology.16 The
most common regiochemical outcome is installation of the
diol ortho,meta to the arene substituent (8, Scheme 2a).17
However,R. eutrophus B918 and certain other organisms19
are able to metabolize benzoate to the corresponding ipso,
ortho diol (10, Scheme 2b). Chiron 10 has found diverse
synthetic applications,20 and we have demonstrated its use
in a concise synthesis of new azacarbasugars.21 The abso-
lute configuration of 10 has been proven.20a,b Great syn-
thetic utility derives from the densely packed, differentiated
functionality in arene dihydrodiols. For example, 8 (R =
C2H3) has been employed in the synthesis of zeylena,
isolated fromUvaria zeylanica.22However, the useof arene
dihydrodiols is sometimes hampered by their facile dehy-
dration/rearomatization at extremes of pH or at elevated
Scheme 1. Proposed Biosynthetic Origin of Grandifloracin
Scheme 2. Regio- and Stereoselectivity of Dioxygenases
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temperature. This decomposition pathway may be shut
down by protection of the diene as a tricarbonyliron(0)
complex. Many dienes of type 8 have been complexed in
this fashion,23 and we have recently extended this metho-
dology to derivatives of 10.24 The iron complex serves not
only as a protecting group but also allows access to new
reactivity, e.g., formation of cationic η5 dienyl complexes.
In the present work, the combination of diol acid 10 with
tricarbonyliron methodology permits rapid assembly of
(þ)-grandifloracin 1.
Diol acid 10 was treated with TMS-diazomethane to
afford methyl ester 11. Exposure of this to nonacarbonyl
diiron gave complex 12 as the sole diastereoisomer, as
proven previously by crystallography.24a Reduction of 12
with diisobutylaluminumhydride furnished triol 13, which
was used crude due to its instability. The success of this
reduction illustrates the necessity of using the iron com-
plex, as attempted reduction of the corresponding uncom-
plexed ester 11 results only in aromatization under all
conditions we have tried. Selective access to benzoate 14
proved problematic, with appreciable benzoylation at the
secondary alcohol also observed. It was established that
premixing benzoyl chloride and 2,4,6-collidine prior to
addition to 13 minimized formation of dibenzoate 15
(Scheme 3).25
In order to circumvent problems of overacylation, an
alternative route was explored. Selective silylation of the
secondary alcohol in 11 was followed by iron complex
formation as before (Scheme 4). Notably, the sole diaster-
eomer isolated (17) was again that in which iron complexed
to the lower face, despite the increased steric blockadedue to
the silyl ether (the structurewas confirmed byX-ray crystal-
lography, Figure 2). Reduction was effected as previously
with diisobutylaluminum hydride (the uncomplexed ester
16 once again not being amenable to direct reduction).
Treatment of 18 with BzCl led to monobenzoylation only,
as expected, and TBAF-mediated desilylation furnished 14.
However, the overall yield of 14 by this route (25% from 11)
is inferior to that in Scheme 3 (44% from 11).26
We24a and others27 have shown that in certain cases
MnO2 may be used to effect chemoselective alcohol
Scheme 3. Route to Benzoylated Iron Complex
Scheme 4. Alternate Route Employing Silicon Protection
Figure 2. ORTEP diagram of 17 shows ellipsoids at 50%
probability. H atoms are shown as spheres of arbitrary radius.
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oxidation in tricarbonyliron diene complexes, leaving the
oxidatively labile tricarbonyliron fragment intact. Upon
exposure of 14 to MnO2, complexed cyclohexadienone 20
was accessed in good yield; as expected, this proved inert
with respect to dimerization. The utility of iron complexa-
tion is further underscored by the facile access to 20; upon
attempted oxidationwithMnO2, uncomplexed alcohols 10
and 11 give predominantly rearomatizedmaterial and only
very low yields of cyclohexadienone dimers.28 A second
discrete oxidation of 20 was then required to liberate the
uncomplexed dienone. TrimethylamineN-oxide, although
commonly used for cleavage of tricarbonyliron,29 was
ineffective in the case of 20. Instead, CAN in acetone was
found to unmask the diene giving 6, with spontaneous
dimerization affording (þ)-grandifloracin 1 (six steps from
10, 10% overall yield, Scheme 5).
1H and 13CNMRdata for synthetic 1were in agreement
with those reported for the natural product.1,2 Two values
have been reported for the optical rotation of natural
grandifloracin, [R]D 13.6 (c 0.728, CHCl3)1a and
[R]D 0.02 (c 0.04, CHCl3).2b The measured optical rota-
tion for synthetic grandifloracin 1 is [R]D þ10.6 (c 0.90,
CHCl3). The magnitude of this value accords well
with the first literature value; the opposite sign indicates
that the (þ)-1 we have synthesized is in fact ent-
grandifloracin.
In summary,wehave reporteda concise synthesis of (þ)-
ent-grandifloracin 1 that showcases the synthetic utility of
arene dihydrodiols in conjunction with iron complexation
methodology. The work serves to establish the absolute
configuration of natural ()-grandifloracin. Further work
on the use of arene dihydrodiol 10 and its iron complexes in
total synthesis isunderwayandwill be reported induecourse.
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Scheme 5. Total Synthesis of (þ)-Grandifloracin 1
(28) Both 11 and a derivative protected with a BOM group undergo
oxidation to the corresponding cyclohexa-2,4-dienones upon treatment
with DessMartin periodinane; see refs 20b and 20h.
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